Peter Rahmer - 28 Jul 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Reporting relationship: Chief Corporate Develpment Officer
Issuer ticker: RLAY
Reported as of: 28 Jul 2025
Net transaction value: -$62,947
SEC form: 4
Accepted by SEC: 30 Jul 2025, 16:54:35 UTC
Prior SEC filing: 01 Jul 2025
Next SEC filing: 30 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian Adams, as Attorney-in-Fact

Key filing fact

Peter Rahmer filed Form 4 for Relay Therapeutics, Inc. (RLAY) on 30 Jul 2025.

Key facts

This page summarizes Peter Rahmer's Form 4 filing for Relay Therapeutics, Inc. (RLAY).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Jul 2025, 16:54.

Change

Previous filing in this sequence was filed on 01 Jul 2025.
Current net transaction value: -$62,947.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001959229 Primary reporting owner

Rahmer Peter

Relationship: Chief Corporate Develpment Officer
Address: C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE
Signature: /s/ Brian Adams, as Attorney-in-Fact
Signature date: 30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RLAY transaction

Common Stock

Sale

Transaction value: $5,083
Shares: -1,359
Change %: -0.34%
Price: $3.74
Shares after: 393,722
Date: 28 Jul 2025
Ownership: Direct
Footnotes: F1, F2

RLAY transaction

Common Stock

Sale

Transaction value: $57,864
Shares: -15,724
Change %: -4%
Price: $3.68
Shares after: 377,998
Date: 29 Jul 2025
Ownership: Direct
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units ("RSUs") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

Footnote F2

Includes 199,209 shares underlying RSUs.

Footnote F3

Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

Footnote F4

Includes 156,816 shares underlying RSUs.

SEC remarks

Chief Corporate Develpment Officer